Penserra Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92K Buy
496
+9
+2% +$1.66K ﹤0.01% 770
2026
Q1
$91K Buy
487
+15
+3% +$3.16K ﹤0.01% 737
2025
Q4
$93K Buy
+472
New +$95.4K ﹤0.01% 735
2019
Q1
– Sell
-1,440
Closed -$24K – 797
2018
Q4
$24K Sell
1,440
-316
-18% -$7.65K ﹤0.01% 600
2018
Q3
$49K Buy
1,756
+356
+25% +$11.8K ﹤0.01% 565
2018
Q2
$46K Buy
+1,400
New +$43.5K ﹤0.01% 497

Other funds holding THC

Penserra Capital Management's THC Position: Q2 2026 in Review

Penserra Capital Management increased its Tenet Healthcare (THC) stake by 1.8% in Q2 2026, buying an estimated $1.66K and bringing the position to 496 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #770.

Penserra Capital Management first reported a position in THC in Q2 2018 and has held it in 6 quarters since. The position peaked at $93K in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Penserra Capital Management held 496 shares of Tenet Healthcare worth $92K as of Q2 2026.
  • Penserra Capital Management bought 9 Tenet Healthcare shares in Q2 2026, an estimated $1.66K.
  • Tenet Healthcare made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #770 holding.
  • Penserra Capital Management first reported a position in Tenet Healthcare in Q2 2018 and has held it in 6 quarters since.
  • Penserra Capital Management's Tenet Healthcare position peaked at $93K in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.